EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening.

Autor: Cappelletto, Ambra1 (AUTHOR), Alfì, Edoardo1,2 (AUTHOR), Volf, Nina1 (AUTHOR), Vu, Thi Van Anh1 (AUTHOR), Bortolotti, Francesca3 (AUTHOR), Ciucci, Giulio1 (AUTHOR), Vodret, Simone1 (AUTHOR), Fantuz, Marco4,5 (AUTHOR), Perin, Martina1 (AUTHOR), Colliva, Andrea1 (AUTHOR), Rozzi, Giacomo1 (AUTHOR), Rossi, Matilde1 (AUTHOR), Ruozi, Giulia3 (AUTHOR), Zentilin, Lorena3 (AUTHOR), Vuerich, Roman1,2 (AUTHOR), Borin, Daniele6 (AUTHOR), Lapasin, Romano6 (AUTHOR), Piazza, Silvano7,8 (AUTHOR), Chiesa, Mattia9 (AUTHOR), Lorizio, Daniela9 (AUTHOR)
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 1/10/2024, Vol. 43 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje